Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacologicaltreatment of COVID-19: lights and shadows.
Menzella F, Biava M, Barbieri C, Livrieri F, Facciolongo N. Menzella F, et al. Drugs Context. 2020 May 19;9:2020-4-6. doi: 10.7573/dic.2020-4-6. eCollection 2020. Drugs Context. 2020. PMID: 32499832 Free PMC article. Review.
A survey of clinical features of allergic rhinitis in adults.
Frati F, Dell'Albani I, Passalacqua G, Bonini S, Rossi O, Senna G, Incorvaia C; Adult SURF Study Group. Frati F, et al. Med Sci Monit. 2014 Nov 4;20:2151-6. doi: 10.12659/MSM.891206. Med Sci Monit. 2014. PMID: 25366169 Free PMC article.
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
Verduri A, Luppi F, D'Amico R, Balduzzi S, Vicini R, Liverani A, Ruggieri V, Plebani M, Barbaro MP, Spanevello A, Canonica GW, Papi A, Fabbri LM, Beghè B; FARM58J2XH Study Group. Verduri A, et al. PLoS One. 2015 Mar 11;10(3):e0118241. doi: 10.1371/journal.pone.0118241. eCollection 2015. PLoS One. 2015. PMID: 25760346 Free PMC article. Clinical Trial.
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
Vultaggio A, Aliani M, Altieri E, Bracciale P, Brussino L, Caiaffa MF, Cameli P, Canonica GW, Caruso C, Centanni S, D'Amato M, De Michele F, Del Giacco S, Di Marco F, Menzella F, Pelaia G, Rogliani P, Romagnoli M, Schino P, Senna G, Benci M, Boarino S, Schroeder JW. Vultaggio A, et al. Among authors: menzella f. Respir Res. 2023 May 20;24(1):135. doi: 10.1186/s12931-023-02439-w. Respir Res. 2023. PMID: 37210543 Free PMC article.
Omalizumab: when the non-responder is a late-responder.
Menzella F, Facciolongo N, Castagnetti C, Simonazzi A, Zucchi L. Menzella F, et al. Eur Ann Allergy Clin Immunol. 2009 Oct;41(5):155-9. Eur Ann Allergy Clin Immunol. 2009. PMID: 20101930
110 results